imipramine has been researched along with Protein Aggregation, Pathological in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Areales, FJ | 1 |
| Di Pietro, O | 1 |
| Espargaró, A | 1 |
| Vallverdú-Queralt, A | 1 |
| Galdeano, C | 1 |
| Ragusa, IM | 1 |
| Viayna, E | 1 |
| Guillou, C | 1 |
| Clos, MV | 1 |
| Pérez, B | 1 |
| Sabaté, R | 1 |
| Lamuela-Raventós, RM | 1 |
| Luque, FJ | 1 |
| Muñoz-Torrero, D | 1 |
1 other study available for imipramine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Topics: Acetylcholinesterase; Aminoquinolines; Amyloid beta-Peptides; Antioxidants; Catechols; Cholinesteras | 2014 |